A 51-year-old with newly diagnosed T2DM and ASCVD is on metformin. Which glucose-lowering agent is preferred to reduce CV events?...

Question

A 51-year-old with newly diagnosed T2DM and ASCVD is on metformin. Which glucose-lowering agent is preferred to reduce CV events?

Accepted Answer

GLP-1 receptor agonist with proven CV benefit

Answer

Sulfonylurea

Answer

DPP-4 inhibitor

Answer

Thiazolidinedione

Answer

Basal insulin first-line for all

us-abfm MCQ (SBA): Type 2 Diabetes Mellitus